Introduction
Acetylcholinesterase (AChE) and the nicotinic acetylcholine receptor (nAChR) are the major functional proteins controlling postsynaptic events at the neuromuscular junction and in certain other central and peripheral nervous system synapses. In addition to AChE's and nAChRs common recognition capacity for acetylcholine and certain inhibitors, both proteins show proximal localization in synapses, function within a millisecond time frame and exhibit common features of expression during differentiation in muscle or following denervation [ 1,2]. The fidelity of neuromuscular transmission in the organism and the duration of miniature endplate potentials in individual synapses require that the active states of these proteins be functioning within close stoichiometric confines [ 3 ] . In autoimmune myasthenia gravis, functional receptor is diminished and the disease can be managed by prolonging the presence of acetylcholine in the synapse with AChE inhibitors (41. AChE inhibition by insecticides and a congenital myasthenic state with diminished endplate AChE also lead to compromised synaptic neurotransmission [3,5].
Comparative sequences [6] and an X-ray crystal structure [7] have enabled examination of the structure of AChE and its inhibitor complexes at an atomic level of resolution, whereas the nAChRs disposition within integral membranes makes its crystallization a formidable endeavour.
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Nevertheless, electron microscopy image analysis [8] has provided structural details of the receptor approaching 10 A resolution; this work, along with studies of sequence in relation to function, has contributed to the understanding of details of ligand specificity for the receptor at a molecular level of resolution.
Herein we present an overview of the factors governing ligand specificity and gene expression for these two proteins. Some general structural features prevail for stabilization of the quaternary ammonium moiety of bound ligands. However, the most noteworthy comparative aspects for these proteins do not result from evolutionary divergence of related structures, but rather emerge from parallel, independent evolutionary pathways aimed at achieving specificity and coordinated gene expression.
Gene expression of the nicotinic receptor and AChE
Cholinergic receptors are the products of two large gene families. The five known subtypes of muscarinic receptors are members of the seven membranespanning G-protein-linked receptors. Members of the nicotinic receptor family of receptors exist as ligand-gated ion channels assembled as pentamers of homologous subunits. Since as many as four different subunits can be found in the pentamers and at least 16 different nicotinic receptor subunits have been identified [2, 8, 9] , the possibility for receptor diversity is enormous. Fortunately, not all permutations of subunits associate into functional receptors, and virtually all subunits which primarily contribute to the binding site ( a subunits) require association with non-a subunits to achieve function. Since each gene encoding these subunits has a distinct promoter region, transcription might be expected to be a dominant, differential regulatory mechanism of gene expression.
By contrast, AChE is encoded by a single gene and its structural variations arise from alternative mRNA splicing, yielding three distinct C-termini (Figure 1 ). The portion of the gene encoding the essential catalytic residues is invariant, giving rise to identical catalytic properties for all of the molecular species. The distinct C-termini allow the enzyme to be expressed as: (a) hydrophilic monomers, (b) homomeric dimers and tetramers which vary hydrophobicity through attachment of a fatty acid or exposure of an amphiphatic helix, (c) a glycophospholipid-linked species, and (d) heteromeric oligomers which link via a disulphide to a filamentous, triple-helical collagen unit or a lipidlinked subunit. RNA splicing governs the structural diversity of AChE, but multiplicity of species is further enhanced by post-translational events [ 10,l l].
A second difference between AChE and the nAChR lies in the control of gene expression. Upon differentiation from myoblasts to myotubules, the enhanced expression of the nAChR gene is a consequence of increased transcription [ 12,131. By contrast, we find that enhanced AChE gene expression in the same differentiation scheme arises from stabilization of otherwise rapidly turning over mRNA [14] . Decreased degradation of AChE mRNA with a concomitant increase in mRNA levels appears to be controlled, at least in part, by the release of cellular Ca'+ (Z. Luo, M.-E. Fuentes and P. Taylor, unpublished work). Ca'+ has little influence on the increased expression of the nAChR during muscle differentiation. Only AChE expression shows superinduction after initiation of differentiation of the myoblast and subsequent treatment with cycloheximide [14] . The distinction of transcriptional activation versus mRNA stabilization is shown by comparing (a) transcription rates in myoblasts and myotubes by run-on transcription, (b) transcription rates of reporter genes placed behind the nAChR and AChE promoters, and (c) differential rates of gene expression in cell lines containing or lacking the muscle differentiation genes.
In short, AChE and the nAChR show parallel increases in expression with differentiation and the capacity to express distinct molecular species in different tissues. Surprisingly, this co-ordinated expression employs very different mechanisms to increase the level of mRNA species available for translation.
I Ligand specificity at cholinergic binding sites
The most notable difference between AChE and the nAChR, as two oligomeric proteins, is that the agonist sites in the receptor reside at subunit interfaces ( Figure Z) , whereas AChE's active centre is close to the geographic centre of each subunit at the base of a 18-2OA gorge (Figure 3) . A site at the interface between subunits for ligand binding to the nAChR accords with the co-operativity seen for ligand-gated channel opening and for ligand binding. By contrast, each AChE subunit appears to behave in an independent, non-cooperative fashion.
The crystal structure [7, 15] , sequence comparisons and mutagenesis studies [16] [17] [18] of AChE allow one to define three distinct domains respon- The third domain responsible for ligand specificity lies outside the active centre and resides at the lip of the gorge. This region contributes to the peripheral anionic site. Certain ligands, the prototype of which is propidium, bind to the peripheral site, regulating catalysis in an allosteric fashion [ 101.
Fasciculin, a peptide toxin of molecular mass 6500 Da which is homologous to the three-loop, short a-toxins, also bind to this site. Bisquaternary ligands in which the quaternary groups are separated by at least 1.4 nm span between the peripheral site and the active centre. Site-specific mutagenesis show that at least four residues, W"", Y i z , Y I'" and D i J , encompass the peripheral site. H r x 5 and Y 13" may also be involved. W"", Y' ' and Y"' are replaced with R(A), Q and N respectively in HuChE. Remarkably, substitution at only these three positions to the residues found in IhChE confers HuChE characteristics to this site where fasciculin, propidium and certain bisquaternary ligands bind with markedly lower affinities [ 16,191. Some bisquaternary ligands and propidium probably bind to HuChE with an orientation different to that with which they bind AChE.
Perhaps the most interesting peripheral site ligand is fasciculin, which binds to AChE with a K,, of 2 pM and to HuChE with a K,, of 230 pM. Partitioning of the free energy shows that WZX"R, Y IZ4Q and YiZN can account for the entire specificity difference [20] . Hence this relatively large peptide residing at the lip of the gorge could restrict substrate access and/or allosterically affect the alignment of residues in the active-centre gorge. Although mouse HuChE contains six more glycosylation sites than AChE, glycosylation is not a factor influencing fasciculin binding.
Ligand specificity at the nAChR
The absence of a high-resolution structure of the nAChR necessitates a different approach to the analysis of structure. Site-directed labelling with gents [21] and natural conjugating toxins [22] have defined candidate residues involved in agonist and antagonist binding to the receptor. Reactive residues in the a subunit include C'", CIy3 7 , Yy' Yl'"), Y Iyx and W4'. Additional insights into the structural basis for conferring specificity and into how these residues affect the functional states of the receptor, i.e. the fractions in the open channel, activatible and desensitized states, come from mutagenesis.
Inserting mutations at residues where sequence differences between species might be responsible for functional differences offers a second approach. This approach, for example, enabled us to define residues responsible for conferring resistance to snake a-toxins for the snake and mongoose nAChR [23] . By selecting sequence differences [ 241, we have determined that glycosylation signals at NIX" in snake and NIx7 in ' mongoose confer resistance to the a-toxin. This interference from presumed steric hindrance is seen with the 6800Da a-toxins but not for the 1500Da aconotoxin or the 500Da lophotoxin. The observation that only glycosylation affects a-toxin binding differs from data acquired with isolated peptides and fusion proteins [25] and probably reflects the necessity of a proper apposition of amino acid residues at the subunit interface to achieve ligand specificity.
The third approach relies on distinct sequences in the domains of the y and 6 subunits associating with the same interface of a. As shown in Figure 3 , the counterclockwise face of a will associate with the clockwise face of y and 6. These two interfaces form the two binding sites for agonists. When the dissociation constants at these sites differ, it becomes possible through substitutions in y and 6 to define residues contributing to the interfacial binding sites [26] . This approach has been used to define the residues that contribute to a 100-fold preference of a y over a d in d-tubocurarine binding [27] . An even more dramatic example is the 10'-fold preference in a-conotoxin binding found for the a6 over that of the a y interfaces [24] . A two-subunit transfection of a y or a6 yields dimeric receptor with appropriate ligand-binding properties. For example, the difference in specificity seen for the a y in an intact pentameric receptor can be replicated in assembled dimers. However, the assembled dimers do not reach the cell surface.
chemically reactive reagents [20] , photoreactive rea-'742
Three subunit transfections of spy, or a/3d yields pentameric a,&, and a,Bd, which are expressed on the cell surface as is the native a#$. Only the four subunit transfection a@yd gives the requisite cooperativity seen in the intact receptor [28] .
In the case of the receptor, we chose to study the binding, at the primary site of acetylcholine recognition between subunits, of a-toxin (i.e. abungarotoxin, cobra a-toxin and erabutoxin). Binding of these three-fingered a-toxins is prevented competitively by agonists and the presumed site lies within the subsite interface. Reactions are slow (four orders of magnitude slower than diffusion) and glycosylation presumably diminishes a-toxin access.
The fasciculins are three-fingered peptide toxins, homologous to the a-toxins, that bind to AChE. By contrast, fasciculin binding is not competitive with substrate or active-site ligand; the differences in AChE and BuChE specificity are attributable to particular aromatic side chains at the lip of the gorge outside the active site. Glycosylation plays no role in the specificity difference. Hence, only in the case of a-toxin association with the receptor is the site of inhibition the primary acetylcholine recognition site.
Receptor subunit assembly
Studies of the influence of particular residues on the properties at a subunit interface possess the potential advantage that mutations can be matched in paired subunits to ascertain whether complementarity is required for either ligand binding or subunit assembly. In the case of the receptor, the assembling subunits can be examined as dimers after transfection of a y or a d into cells not expressing receptor [26] . The a subunit alone binds atoxin but with an affinity that is far lower than the intact receptor. Moreover, agonists ineffectively compete with a-toxin binding to the monomeric receptor. With the dimers, a-toxin and agonist affinities are increased. The pentameric receptor gives a better representation, but only the four-subunit pentamer a,/3yd shows co-operativity. Just as in the case for ligand binding, the N-terminal 200 residues dictate subunit assembly, and this approach has enabled us to define residues and domains present on the clockwise and counterclockwise face of each subunit.
Summary
The functional design of the nAChR and AChE rather than their recognition capacities requires divergence in structure of the two binding sites. The receptor requires co-operativity to link ligand occupation to the response, rapid conformational transitions of activation, and slower transitions of desensitization. Hence, its binding sites have evolved at subunit interfaces. By contrast, AChE functions with a large k,,, and a comparatively large K,. To do so, it must force acetylcholine through a low-energy transition site that features tetrahedral rather than the ground-state, trigonal conformation around the carbonyl carbon. This requires a high affinity (K,, -lo-'' M) for the enzyme complex of the transient transition state. Interestingly, the threefinger peptide toxins (a-bungarotoxin and fasciculin), though closely homologous, use different interaction sites on the receptor (the agonist recognition site) and AChE (a peripheral site). Finally, although the two proteins show co-ordinated expression during muscle differentiation, the receptor relies primarily on transcriptional control while AChE expression is post-transcriptional, being controlled by mRNA stability.
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